Aug. 18 at 9:12 PM
$NYXH 25K per device. if they get 1000 patients , we are at 25mil in revenue. mcap for this is 200m. To compare
$INSP had sales of more than 200m this past Q, for arguably a not as good a product . Might take some time, but this has a potential of a 100-200% gain in a year or so.